Market Place
Sourcing Support
All News #Library
Others
iECURE Gets FDA Fast Track For OTC Deficiency Therapy
07 May 2024 //
BUSINESSWIRE
iECURE Announces FDA Clearance of NDA for ECUR-506 to Initiate Trial
04 Apr 2024 //
BUSINESSWIRE
iECURE Appoints Gabriel M. Cohn, M.D., as Chief Medical Officer
16 Mar 2023 //
BUSINESSWIRE
iECURE gets fresh $65M to push pediatric liver disease gene therapy into clinic
30 Nov 2022 //
ENDPTS
Preclinical Data from iECURE’s GTP-506 shows Potential for OTC Deficiency
19 Oct 2022 //
BUSINESSWIRE
iECURE Receives FDA Orphan Drug Designation for GTP-506
06 Sep 2022 //
BUSINESSWIRE
iECURE Receives FDA Rare Pediatric Disease Designation for GTP-506
23 Aug 2022 //
BUSINESSWIRE
iECURE Enters Agreement with Center for Breakthrough Medicines
27 May 2022 //
CONTRACTPHARMA
Precision Bio Reports Q3 2021 Financial Results, Provides Business Update
10 Nov 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.